Determinants of medication use for the secondary prevention of cardiovascular disease
<p>Previous studies have shown that use of effective and widely recommended treatments, specifically statin and antiplatelet therapy, for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD) is suboptimal. However, knowledge regarding the underlying reasons for suboptimal...
| Հիմնական հեղինակ: | |
|---|---|
| Այլ հեղինակներ: | |
| Ձևաչափ: | Թեզիս |
| Լեզու: | English |
| Հրապարակվել է: |
2021
|